4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-21-024444
Options or other derivatives
- Director acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Levy Caroline S Director | 2021-12-01 | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | D | ||
Loading xslF345X03/wf-form4_163848152738878.xml…